• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,802.90 -607.08
( -0.78%)
Global Indices
Nasdaq
51,584.84 71.29
(0.14%)
Dow Jones
7,519.91 78.81
(1.06%)
Hang Seng
70,971.12 -82.37
(-0.12%)
Nikkei 225
10,394.87 -113.74
(-1.08%)
Forex
USD-INR
94.51 -0.04
(-0.04%)
EUR-INR
109.43 -0.23
(-0.21%)
GBP-INR
126.51 -0.33
(-0.26%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
39.46
975.13
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.06
 

sanmit infra ltd
NBCC jumps on bagging consultancy orders worth Rs 21-cr
Jun 16,2026

The first order, valued at around Rs 8.48 crore, has been awarded by Chennai Port Authority for undertaking improvement works to the Medical and Surgical Blocks of the Chennai Port Authority Hospital at Chennai.

The second order, worth about Rs 12.44 crore, has been received from Power Grid Corporation of India Ltd (PGCIL) for the construction of a 150-bed Vishram Sadan at the Government General Hospital in Kurnool, Andhra Pradesh.

Both contracts have been awarded by domestic entities and pertain to project management consultancy services.

NBCC said neither of the awarding entities is related to the company's promoter or promoter group, and the contracts do not fall under related-party transactions.

The total value of the two orders stands at approximately Rs 20.92 crore.

NBCC (India) operates in three major segments—project management consultancy, real estate, and engineering procurement & construction.

The company’s consolidated net profit jumped 37.22% to Rs 241.38 crore on 1.81% rise in revenue from operations to Rs 4559.79 crore in Q4 FY26 over Q4 FY25.